Haven't had much time lately? Here's what you may have missed in the last few months
27 Apr 2017
Ovarian cancer patients with platinum-sensitive recurrence may benefit from a bevacizumab regimen given alongside paclitaxel and carboplatin
26 Apr 2017
Adding a hepatic arterial infusion to systemic chemotherapy may boost overall survival after complete resection of colorectal cancer liver metastases
25 Apr 2017
Human papillomavirus-positive oropharyngeal squamous cell carcinoma may have increased radiation sensitivity that could allow a reduced dose radiotherapy...
24 Apr 2017
Nivolumab could be a potential treatment option for patients with advanced hepatocellular carcinoma
21 Apr 2017
Tumoural expression of programmed cell death ligand 1 could help identify patients with colorectal cancer who may benefit from aspirin use after cancer...
During ESMO Signalling Pathways 2017 held in partnership with EACR, we met with Timothy Yap, M D Anderson Cancer Center, US. He discusses different issues about BRCA related cancers. BRCA Mutations are particularly relevant for patients with ovarian, prostate and breast cancer. Besides the cancer risk, he also elaborates the therapeutic implications especially in term of PARP inhibition.
20-21 Feb 2017, Zurich, Switzerland